These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27147715)

  • 1. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study.
    Downes KJ; Weiss SL; Gerber JS; Klieger SB; Fitzgerald JC; Balamuth F; Kubis SE; Tolomeo P; Bilker WB; Han X; Nachamkin I; Garrigan C; Han JH; Lautenbach E; Coffin SE;
    J Pediatric Infect Dis Soc; 2017 Jun; 6(2):134-141. PubMed ID: 27147715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.
    Downes KJ; Fitzgerald JC; Schriver E; Boge CLK; Russo ME; Weiss SL; Balamuth F; Kubis SE; Tolomeo P; Bilker WB; Han JH; Lautenbach E; Coffin SE; Gerber JS
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):36-43. PubMed ID: 30476186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
    Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
    Pavcnik-Arnol M; Hojker S; Derganc M
    Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
    Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
    Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
    Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
    Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
    Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
    Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children.
    Groselj-Grenc M; Ihan A; Pavcnik-Arnol M; Kopitar AN; Gmeiner-Stopar T; Derganc M
    Intensive Care Med; 2009 Nov; 35(11):1950-8. PubMed ID: 19756501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
    Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
    J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a diagnostic model for early differentiation of sepsis and non-infectious SIRS in critically ill children - a data-driven approach using machine-learning algorithms.
    Lamping F; Jack T; Rübsamen N; Sasse M; Beerbaum P; Mikolajczyk RT; Boehne M; Karch A
    BMC Pediatr; 2018 Mar; 18(1):112. PubMed ID: 29544449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Concentrations of Interleukin-6, Procalcitonin, and C-Reactive Protein: Discrimination of Septical Complications and Systemic Inflammatory Response Syndrome after Pediatric Surgery.
    Neunhoeffer F; Plinke S; Renk H; Hofbeck M; Fuchs J; Kumpf M; Zundel S; Seitz G
    Eur J Pediatr Surg; 2016 Apr; 26(2):180-5. PubMed ID: 25643248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.
    Casado-Flores J; Blanco-Quirós A; Asensio J; Arranz E; Garrote JA; Nieto M
    Pediatr Crit Care Med; 2003 Apr; 4(2):190-5. PubMed ID: 12749651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit.
    Tian G; Pan SY; Ma G; Liao W; Su QG; Gu BC; Qin K
    J Clin Neurosci; 2014 Jul; 21(7):1153-8. PubMed ID: 24508074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.
    Arkader R; Troster EJ; Lopes MR; Júnior RR; Carcillo JA; Leone C; Okay TS
    Arch Dis Child; 2006 Feb; 91(2):117-20. PubMed ID: 16326799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study.
    Lanziotti VS; Póvoa P; Prata-Barbosa A; Pulcheri LB; Rabello LSCF; Lapa E Silva JR; Soares M; Salluh JIF
    J Crit Care; 2018 Apr; 44():217-222. PubMed ID: 29161668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.
    Enguix A; Rey C; Concha A; Medina A; Coto D; Diéguez MA
    Intensive Care Med; 2001 Jan; 27(1):211-5. PubMed ID: 11280637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.